Home › Funds › Royce & Associates › WST
Royce & Associates position in WST
WEST PHARMACEUTICAL SVSC INC · Health Care
Latest position (Q2 2022)3.00K sh
Reported value held$907.00K
Portfolio Weight0.01%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 6.00K | $2.55M | New |
| Q4 2021 | 6.00K | $2.81M | Hold |
| Q1 2022 | 6.00K | $2.46M | Hold |
| Q2 2022 | 3.00K | $907.00K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding WST
- Vanguard Group 9.54M sh · $2.62B · Q4 2025
- BlackRock Inc 6.65M sh · $2.39B · Q2 2026
- Fidelity Management & Research (FMR) 3.57M sh · $1.28B · Q2 2026
- BNY Mellon 2.04M sh · $733.73M · Q2 2026
- Geode Capital Management 1.90M sh · $680.55M · Q2 2026
- Morgan Stanley 1.58M sh · $568.14M · Q2 2026
- JPMorgan Chase & Co 1.16M sh · $413.03M · Q2 2026
- Invesco Ltd 1.01M sh · $362.54M · Q2 2026
- Norges Bank Investment Management 862.91K sh · $309.79M · Q2 2026
- Goldman Sachs Group 814.77K sh · $292.50M · Q2 2026
- Northern Trust Corp 709.42K sh · $254.68M · Q2 2026
- Capital Research Global Investors 609.22K sh · $218.71M · Q2 2026